China Life Cancer Guardian: A Focused Plan for Specific Cancer Protection Needs
China Life Cancer Guardian is a non-participating, yearly renewable term life plan offered by China Life Insurance (Singapore) Pte. Ltd. Designed specifically for pure protection, this product provides financial coverage against death and the diagnosis of cancer at any stage during the policy term. Unlike whole life or investment-linked policies, it has no cash value, surrender value, bonuses, or maturity value. The plan is structured to offer a lump sum payout upon the death of the insured or a confirmed cancer diagnosis, with the policy terminating immediately after either event. It is suitable for consumers seeking straightforward, cost-effective coverage for these specific risks without the complexity of savings components.
How it compares
The following comparison uses data from CompareFIRST.sg as of July 2026. All premiums are annual rates per $100,000 sum assured for a 35-year-old male non-smoker. The target product, China Life Cancer Guardian, is compared against similar term life products available in the market.
| Product (Insurer) | Premium/yr per $100k SA | Coverage Term Context |
|---|---|---|
| China Life Cancer Guardian (China Life) | $182 | Yearly renewable (up to age 100) |
| ManuProtect Term Lite (II) (Renewable) (Manulife) | $178 | Renewable options available |
| Star Term Protect (Income Insurance Limited) | $180 | Fixed terms of 21 to 25 years |
| Singlife Simple Term (Singapore Life Ltd.) | $55 | Fixed terms of 1 to 5 years |
In terms of pricing, China Life Cancer Guardian ($182) is positioned in the mid-range among its peers. It is slightly more expensive than ManuProtect Term Lite (II) by Manulife ($178) and significantly higher than Singlife Simple Term ($55). However, direct price comparisons must consider the coverage structure. Singlife Simple Term offers lower premiums but is limited to short fixed terms of 1 to 5 years, whereas China Life Cancer Guardian offers guaranteed renewability up to age 100, providing long-term stability that fixed-term plans do not.
Compared to Star Term Protect by Income Insurance ($180), the pricing is nearly identical. However, Star Term Protect typically operates on fixed longer terms (21–25 years), while Cancer Guardian is a yearly renewable plan. This means premiums for Cancer Guardian will increase annually based on age and prevailing rates, whereas fixed-term plans lock in rates for the duration. ManuProtect Term Lite (II) offers slightly lower initial costs ($178) but includes additional benefits like TPD and CI riders, which may affect its base premium structure differently than a pure cancer-focused plan.
Pros
- Specialized Coverage: Specifically targets cancer risks at any stage, including carcinoma-in-situ, which is broader than some standard critical illness definitions that exclude early-stage cancers.
- Guaranteed Renewability: The policy can be renewed annually without further evidence of insurability until age 100, ensuring coverage continuity even if health status changes.
- No-Claim Discount: Offers an 8% discount on renewal premiums from the second year onwards if no claims were made in the preceding year, helping to mitigate rising age-based premium costs.
- Transparent Exclusions: Clearly defines what is excluded (e.g., pre-existing conditions, specific skin cancers, HIV-related tumors), reducing ambiguity for policyholders.
Cons
- Premium Volatility: As a yearly renewable plan, premiums are not guaranteed and will increase with the insured’s age, potentially becoming unaffordable in later years.
- No Savings Component: Being a pure protection plan, it has no cash value or maturity benefit; if no claim is made, the premiums paid are not returned.
- Strict Cancer Definition: Requires histological confirmation for diagnosis; clinical diagnoses alone do not qualify, and certain early-stage or non-invasive tumors are excluded from coverage.
- Waiting Period: A 90-day waiting period applies to cancer benefits, meaning no payout if symptoms appear within this timeframe after issuance or reinstatement.
Who it may suit
China Life Cancer Guardian is best suited for individuals who want dedicated, long-term protection against cancer risks without the higher costs associated with comprehensive critical illness plans that include savings elements. It is particularly relevant for those who are concerned about the rising cost of cancer treatment and desire guaranteed renewability to ensure coverage remains in place as they age. It may also appeal to consumers who prefer a simpler policy structure with clear, defined benefits for death and cancer only, and who value the no-claim discount feature to help manage long-term costs. Consumers seeking short-term, low-cost coverage might find Singlife Simple Term more suitable, while those wanting broader critical illness coverage might look at ManuProtect Term Lite (II).
This is general information based on CompareFIRST.sg data, not financial advice. Premiums and features can change; please verify with the insurer or a MAS-licensed financial adviser before making any decision.
How it compares
Like-for-like against the nearest plans from other insurers · all figures per $100,000 sum assured.
| Product | Insurer | Premium/yr | Surrender yr20 | Net return 5y | TER 5y |
|---|---|---|---|---|---|
| China Life Cancer Guardian | China Life Insurance (Singapore) Pte. Ltd. | $182 | — | — | — |
| ManuProtect Term Lite (II) (with TPD Plus & CI) (Renewable) | Manulife (Singapore) Pte. Ltd. | $178 | — | — | — |
| Star Term Protect | Income Insurance Limited | $135 | — | — | — |
| Singlife Simple Term | Singapore Life Ltd. | $205 | — | — | — |
Sample premiums (cheapest first)
| Age | Gender | Smoker | Sum assured | CI | Term | Annual |
|---|---|---|---|---|---|---|
| 20 | M | N | $50,000 | Y | Above 40 | $98 |
| 30 | M | N | $50,000 | Y | Above 40 | $100 |
| 31 | M | N | $50,000 | Y | Above 40 | $102 |
| 32 | M | N | $50,000 | Y | Above 40 | $104 |
| 20 | M | Y | $50,000 | Y | Above 40 | $108 |
| 35 | M | N | $50,000 | Y | Above 40 | $114 |
| 30 | M | Y | $50,000 | Y | Above 40 | $116 |
| 31 | M | Y | $50,000 | Y | Above 40 | $124 |
| 20 | F | N | $50,000 | Y | Above 40 | $128 |
| 25 | M | N | $100,000 | Y | Above 40 | $138 |